Laws banning smoking at workplaces and other public places are associated with a significantly lower risk of cardiovascular disease, according to a new study.
Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.
Within the Institute for Public Health and Medicine (IPHAM), investigators collaborate at the intersection of public health and medicine — connecting clinics to communities and accelerating innovations that impact the health of both patients and populations.
A home-based exercise program, consisting of wearables and telephone coaching, did not improve walking endurance for patients with peripheral artery disease, according to a study published in JAMA.
A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.
Scientists throughout Feinberg are deeply invested in identifying health disparities — those differences in health outcomes between populations — as well as exploring novel interventions.
At Keep Your Heart Healthy events, Feinberg medical students provide cardiovascular disease risk assessment and prevention counseling to underserved communities.
Mary McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine and of Preventive Medicine, has been named a Distinguished Scientist by the American Heart Association (AHA).
A Northwestern Medicine clinical trial found that a stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements.
An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.